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Abstract [Word count: 249] Background
Depression trajectories among primary care patients are highly variable, making it difficult to identify patients that require intensive treatments or those that are likely to spontaneously remit. Currently, there are no easily implementable tools clinicians can use to stratify patients with depressive symptoms into different treatments according to their likely depression trajectory. We aimed to develop a prognostic tool to predict future depression severity among primary care patients with current depressive symptoms at three months.
Methods
Patient-reported data from the diamond study, a prospective cohort of 593 primary care patients with depressive symptoms attending 30 Australian general practices. Participants responded affirmatively to at least one of the first two PHQ-9 items. Twenty predictors were pre-selected by expert consensus based on reliability, ease of administration, likely patient acceptability, and international applicability. Multivariable mixed-effects linear regression was used to build the model.
Results
The prognostic model included eight baseline predictors: depressive symptoms, anxiety, history of depression, self-rated health, chronic physical illness, living alone, and perceived ability to manage on available income. Discrimination and calibration (agreement between predicted and observed symptom scores) were acceptable and comparable to other prognostic models in primary care.
Introduction
Mental health disorders account for 7.4% of the total disease burden with depression the main contributor. (Whiteford et al., 2013) Most people seeking help for depressive symptoms are treated in primary care, (Australian Bureau of Statistics, 2011; Australian Institute of Health and Welfare, 2015) and around one quarter of primary care attendees report current depressive symptoms. (Gunn et al., 2008; Herrman et al., 2002) Ten percent of attendees with subthreshold symptoms and no history of depression develop major depression over six months (Davidson et al., 2015) and 21% over two years. (Karsten et al., 2011) Nearly 60% of those with current major depression meet criteria for major depression at least once over the next three years. (Stegenga et al., 2012) In a busy primary care practice, it can be difficult for clinicians to identify which patients with current depressive symptoms are likely to recover and which are likely to worsen, and to provide treatment appropriate for each trajectory. Primary care clinicians are often criticised for either over-treating patients with subthreshold depression (Davidson et al., 2015) or for not providing minimally adequate treatment for patients with major depression. (Wang et al., 2007) One systematic approach to informing clinician's treatment decisions is to use a clinical prediction tool.
A clinical prediction tool is built around a prognostic model that uses clinical and psychosocial information to predict future depression severity. The clinical prediction tool uses the information provided by the prognostic model to stratify patients into different depression severity groups. Type and intensity of treatment is tailored to each group to optimise clinical outcomes with the least intensive treatment. (Rubenstein et al., 2007) To date, no such clinical prediction tool exists that can be used to stratify primary care patients with depressive symptoms into different treatment options based on their predicted depressive symptoms.
We also conducted a literature search to identify existing prognostic models that would be suitable for inclusion in a clinical prediction tool that predicts future depressive symptoms in primary care patients with depressive symptoms, ranging from sub-threshold to severe. The literature search identified nine different prognostic models for depression developed using data from five unique primary care studies. Only two of the models focussed on predicting future depression within samples experiencing current depressive symptoms. (Dowrick et al., 2011; Rubenstein et al., 2007) Of the remaining studies, three developed or validated prognostic models to predict the onset of depression (primary prevention) (Bellon et al., 2011; King et al., 2013; King et al., 2008) , two studies developed a prediction rule to screen for the presence of current mood disorders (Vohringer et al., 2013; Zuithoff et al., 2009 ) and two studies developed algorithms to predict treatment response to antidepressants (Chekroud et al.; Perlis, 2013) .
Of the two studies that developed prognostic models to predict future depression among people with current depressive symptoms, neither was suitable for inclusion in a clinical prediction tool. (Dowrick et al., 2011; Rubenstein et al., 2007) In the first study, the prognostic model developed using trial data from 220 participants in the THREAD study was insufficiently robust to use in the clinical prediction tool because it had low prognostic accuracy. (Dowrick et al., 2011) Furthermore, the development sample only included participants with mild to moderate depression, thus could not be generalised to new primary care patients who present with severe depression. The second study described the development of the Diagnostic Prognostic Index, which was derived using data from 1471 primary care attendees with current major depression participating in one of four randomised trials. (Rubenstein et al., 2007) The Diagnostic Prognostic Index was also unsuitable because the development sample excluded patients with subthreshold depression. Given that in primary care subthreshold depression makes up the largest group of patients presenting with depressive symptoms, the prognostic model would not be generalisable to this population.
Additionally, the Diagnostic Prognostic Index, consisting of over 60 items, would be too lengthy to administer in a primary care waiting room or during a consultation, limiting its usability and usefulness in routine clinical practice. (Toll et al., 2008) This study aimed to develop a prognostic model for future depression severity among adult primary care attendees with current depressive symptoms, ranging from sub-threshold to severe depression. To increase the utility and uptake of the clinical prediction tool we aimed to develop a model with relatively few items that were easy to collect in routine practice. (Toll et al., 2008) 
Methods

Source of data
We developed a prognostic model using data from the diamond (Diagnosis, Management and Outcomes of Depression) cohort study. Diamond is a 10-year prospective study of adult primary care patients with depressive symptoms. (Gunn et al., 2008) Cohort participants were recruited from 30 general practitioners (GPs) working at 30 different urban, regional and rural practices in Victoria, Australia between January and December, 2005. Details of recruitment are published elsewhere. (Gunn et al., 2008) Depression severity was measured using the Patient Health Questionnaire (PHQ-9). (Kroenke et al., 2003; Spitzer et al., 1999) The PHQ-9 is a reliable and valid measure to assess and monitor severity of depressive symptoms over time in primary care. (Kroenke et al., 2001; Spitzer et al., 1999) To reflect usual practice, where only individuals likely to have current depressive symptoms would be administered the clinical prediction tool, the model was derived on 593 (75.2% of 789) cohort participants who scored >2 on the first two items on the Patient Health Questionnaire (PHQ-2). (Kroenke et al., 2003; Spitzer et al., 1999) That is, they reported that in the last two weeks they were bothered by 'little interest or pleasure in doing things' and 'feeling down, depressed, or hopeless' on 'several days' or reported having one or both problems on 'more than half the days' or 'nearly every day'. This threshold ensured that most cases of major depression were not missed (sensitivity=92.7%), but less likely to exclude individuals that did not satisfy formal criteria for major depression (specificity=73.7%). (Kroenke et al., 2003) Ethics approval and consent to participate 
Outcome
The outcome was depressive symptoms at three months, calculated by summing the nine items of the PHQ-9, (Spitzer et al., 1999) with scores ranging from 0 to 27. (Kroenke et al., 2001 ) If two or fewer items on the PHQ-9 were missing the missing values were substituted with the mean response of the completed items, otherwise they were coded as missing. (Kroenke et al., 2010) Depressive symptom severity was stratified according the cutpoints nominated by Kroenke et al; (Kroenke et al., 2001 ) specifically, minimal (0-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27).
Predictor selection
Over forty candidate predictors were considered for the model development. We identified potential predictors from the literature and through consensus opinion by a multi-disciplinary expert group. Variables included were patient demographics, history of depression or anxiety, health service use, antidepressant use, physical health, social support, social functioning and life events. (Gunn et al., 2008) We also considered potentially sensitive questions that, although they are associated with depression, may be distressing for some respondents (e.g. childhood abuse, intimate partner violence, obsessive, or compulsive behaviours).
Twenty predictors were selected for model development (See Supplementary Table) . Five were potentially sensitive questions. Inclusion criteria for predictors for the model building were: easily administered (e.g. not time-consuming), reliable, internationally applicable, publicly available and measured in the diamond study. We also imposed criteria for data quality: less than 10% missing values; distribution not severely skewed and range of values not too narrow.
Sample size
There are no generally accepted methods for sample size calculations for building prognostic models. (Moons et al., 2009b; Steyerberg, 2009 ) Data from 593 participants were available for the development sample. Restricting the candidate predictors to 20 for the model development ensured there were approximately 30 observations per predictor which is sufficient to build a reliable model. (Steyerberg, 2009) 
Statistical analysis and missing data assumption
Analyses were conducted using Stata version 13.1. Mixed effects linear regression, treating general practice as a random effect and predictors as fixed effects, was used to build the model. Under this model, data were assumed missing at random (MAR) conditional on the variables included in the model. (White et al., 2012) 
Model development
Initially, all candidate predictors were included in a full model. Variables were dropped if the regression coefficient was close to zero (< 0.5 mean change per unit change on the variable) and the p-value was greater than 0.5. Adjacent categories for ordinal variables "managing on available income" and "self-rated health" were collapsed because the numbers of individuals in some of the categories were small. (Steyerberg, 2009 ) Adjusted R 2 measure was used to assess model fit with a penalty for model complexity. Model adequacy and robustness to outliers and influential values were examined with overall goodness of fit statistics and regression diagnostics, including residuals and identifying influential values. Two models were derived using this model building process. The first full model included fifteen predictors that were considered easy to collect and likely to be acceptable to respondents (minimising missing data). The predictors included: current depression severity, current anxiety, past depression and anxiety, chronic illness, self-rated health, antidepressant use, ability to manage on available income, social support, negative life events, living alone and exercise. The items "Have you ever been bothered by feeling down, depressed, or hopeless for longer than two weeks" and "Have you ever been bothered by little interest or pleasure in doing things for longer than two weeks" were combined into a single variable "Ever had depression/little interest" if both items were scored 'Yes'. The item "Depression in the past 12 months" met criteria for inclusion in Model 1, but was excluded because it was highly correlated with "Ever had depression/little interest" and baseline "PHQ-9 depression symptom severity" and contributed minimal independent information. The two depression items retained reflected both current (past two weeks) and lifetime depression. The second model included five additional potentially sensitive predictors. We repeated the model building process using all 20 predictors to determine whether including potentially sensitive predictors further improved the model performance.
To adjust for over-optimism, a uniform shrinkage factor can be multiplied with the model coefficients. A shrinkage factors was calculated using a heuristic formula that accounted for the number of predictors considered in the model building process. (Steyerberg, 2009) 
Model performance
Model discrimination was assessed with the concordance (c) statistic, where the 95% confidence interval was calculated using bootstrap resampling for clusters and individuals.
Calibration was assessed with the calibration plot where the observed depressive symptoms (y-axis) were plotted against the predicted scores (x-axis). Perfect predictions would lie on the line of identity.
Stratification by predicted depressive symptoms
Participants were stratified into three groups based on their predicted depressive symptoms: minimal/mild (<=10), moderate (>10 and <13) and severe (>=13). The cut-points were based on the 50 th and 75 th percentile values of the predicted values. These percentiles reflect the percentage of participants stratified into three severity groups: minimal/mild (0 to 9), moderate (10 to14) and moderately severe/severe (15 to 27), based on the observed depressive symptoms at three months. (Kroenke et al., 2001 )
Results
Participants
Distribution of participant characteristics in the development sample are shown in Table 1 .
The fraction of missing responses for each predictor variable for the development sample was small, ranging from zero for gender to 2.2 percent (13/593) for ever being afraid of a partner.
Most participants (91%, 538/593) had complete data for the 20 candidate predictor variables, including the sensitive questions. Fourteen percent (82/593) had missing values for the outcome. Model 1 explained 39.2% of the variation in three-month depression severity (Table 2) .
Model development
Depression symptom severity scores were predicted using the coefficients for Model 1 and Model 2 (Table 2) respectively and the predictor values at baseline. Predicted depression severity for the 593 participants using Model 1 was similar to the mean observed depression severity at three months (n=511, mean=10.7, SD=6.2, range 0 to 27). Figure 1 shows that agreement between the observed and predicted values for the depressive symptoms was acceptable. Model performance did not improve with the inclusion of additional sensitive items (Model 2). Table 3 shows the distribution of the observed depression severity groups at three months across the three predicted severity groups. When predicted and observed depression severity scores were stratified into the three groups the c-statistic was 0.74 (95% CI: 0.70 to 0.78).
Stratification of depressive symptoms
Discussion
We developed a brief, easily administered prognostic model to predict depression severity at three months in adult primary care patients with current depressive symptoms. The eight predictors were depressive symptoms, current anxiety, history of depression, self-rated health, chronic physical illness, living alone, and perceived ability to manage available on income. The final model consists of 17 questions, nine of which are from the PHQ-9.
Including potentially sensitive or distressing questions did not improve the model performance, probably due to correlations with other indicators in the model. The simpler, user-friendly model could be administered in the waiting room or during a consultation and has the potential to be incorporated into routine clinical practice. (Toll et al., 2008) The overall performance of the model measured by the R 2 was 39.2% in the development sample, well above 20% that is commonly found in prognostic research. (Steyerberg, 2009) Compared to the Diagnostic Prognostic Index, where the R 2 was 33% in the development sample, (Rubenstein et al., 2007) our model performed slightly better with substantially fewer items. The R 2 indicates the predictability of the outcome, and models that explain more the 20% of the variability have the potential to be clinically useful and warrant further evaluation and development. (Rubenstein et al., 2007; Steyerberg, 2009) The prognostic model we developed has acceptable discrimination and calibration. A cstatistic of 0.74 was comfortably within the typical range of 0.60 and 0.85 for prognostic models predicting depression onset, (Bellon et al., 2011; King et al., 2008 ) current major depression, (Vohringer et al., 2013; Zuithoff et al., 2009) or, treatment depression outcome (Chekroud et al., 2016; Perlis, 2013) in primary care and in other health settings. (Toll et al., 2008) 
Strengths
Using the diamond cohort provided a strong study design to develop the prognostic model. (Moons et al., 2009a) We were able to prospectively map the natural course of depressive symptoms over time, (Gunn et al., 2013) and use predictors that were well defined and reproducible which increases the generalisability of the model. (Moons et al., 2009a) Unlike many prognostic models which are developed in secondary care and then applied to primary care, (Moons et al., 2009a) our prognostic model was specifically developed for use in general practice using data collected from general practice attendees. The model development using linear regression to predict the depression symptom scores maximised the available information, increased the statistical efficiency (Steyerberg, 2009) and enabled us to consider categorisation of the predictions as a final step rather than an initial one. Our approach to selecting the candidate predictors using information from several sources and limiting their number to 20 ensured that over-fitting was not a threat to the internal validity and generalisability of the model. Steyerberg, 2009) The development sample included patients with depressive symptoms ranging from sub-threshold to severe that reflects the wider patient base seen in primary care. (Herrman et al., 2002) A prognostic model of excessive complexity was not feasible with the modest development sample size. (Steyerberg, 2009) 
Further research
We have incorporated the prognostic model into a web-based clinical prediction tool that stratifies primary care attendees into three groups (i.e., mild, moderate, or severe) based on their predicted depression severity at three months and then provides a matched treatment recommendation. Pilot work showed the clinical prediction tool was acceptable and feasible to use with primary care clinicians and patients. A randomised controlled trial is currently testing the clinical and cost effectiveness of the tool to reduce depressive symptoms, a key step in evaluating the impact of the clinical prediction tool in routine primary care. (Moons et al., 2009a) The trial data also provide the opportunity to externally validate and if required update the prognostic model. (Moons et al., 2009a) 
Conclusion
We developed a brief, easily administered prognostic model for use in primary care across the depressive symptom range to predict depression severity at three months. A clinical prediction tool utilising this model has the potential to assist clinicians manage the large burden of mental health symptoms presenting to primary care. Widespread implementation of tools like this offers the best chance of ensuring that limited resources are allocated based on need. Severe (15-27) 188 (31·7) Count (percentage) presented unless otherwise stated Development sample: 30 GPs, 593 patients, mean cluster size=20, range 6-32 * Candidate predictor variables selected for the model building process † Hazardous drinking in the past 12 months measured using the "The Fast Alcohol Screening Test" (Hodgson et al., 2002) ‡ Potentially sensitive questions § No partner coded as "No" (27) 68 (26) 41 (34) 29 (22) Severe 139 (27) 24 (9) 29 (24) 86 (66) Count (percentage) presented * Cut-points used for the observed depressive symptoms were nominated by Kreonke et al, 2001 † Predicted scores estimated using Model 1; The cut-points used to stratify participants as mild, moderate and severe using the predicted depressive symptom scores were: less than 10; 10 to 13; 13 or more 
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